About Damora Therapeutics Inc
- Industry: Biotechnology
- Exchange: NASDAQ NMS - GLOBAL MARKET
- Country: US
- Website: https://galecto.com/
Frequently Asked Questions
What is the 52-week range for DMRA?
The 52-week high is $34.89 and the 52-week low is $16.5001.
What is the P/E ratio for DMRA?
The P/E ratio data is currently unavailable.
What is the dividend yield for DMRA?
This company does not currently pay a dividend or the data is unavailable.
What is the Return on Equity (ROE)?
The trailing twelve months (TTM) Return on Equity is -83.06%.
What is the Net Profit Margin?
Net Margin data is currently unavailable.
What is the Price to Book (P/B) Ratio?
P/B ratio data is currently unavailable.
Analyst Recommendation Trends
Wall Street analyst consensus for DMRA over the last few months:
Latest DMRA News
Wedbush Reiterates Outperform on Damora Therapeutics, Maintains $40 Price Target
Wedbush analyst David Nierengarten reiterates Damora Therapeutics (NASDAQ:DMRA) with a Outperform and maintains $40 price target.
Guggenheim Maintains Buy on Damora Therapeutics, Raises Price Target to $60
Guggenheim analyst Brad Canino maintains Damora Therapeutics (NASDAQ:DMRA) with a Buy and raises the price target from $40 to $60.
Damora Therapeutics: Potential Payday Is A Long Way Off
Damora Therapeutics targets myeloproliferative neoplasms with a pipeline led by DMR-001, now in Phase 1/1b trials. Learn why DMRA stock is a hold.
Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BOSTON, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Damora Therapeutics, Inc. (NASDAQ: DMRA) (“Damora”), a biotechnology company working to fundamentally redefine care for patients with blood disorders, today announced that it granted equity awards to three newly-hired, non-executive employees on September 1, 2026. The inducement grants were approved by Damora’s independent Compensation Committee of its Board of Directors and were made as material inducements to such individuals’ acceptance of employment
Related Stocks (Peers)
Recent Insider Transactions
| Date | Name | Shares Changed | Price | Value |
|---|---|---|---|---|
| 2026-09-25 | Jarrett Jennifer | +12,500 | $20.23 | $252,875 |
| 2026-08-12 | Cheng Andrew | +30,350 | - | - |
| 2026-07-06 | Winslow Garrett | -245 | $29.98 | $7,345 |
| 2026-07-03 | Winslow Garrett | -680 | - | - |
| 2026-07-03 | Winslow Garrett | +680 | - | - |
| 2026-03-30 | Jarrett Jennifer | +1,500,000 | - | - |
| 2026-03-30 | Jarrett Jennifer | +500,000 | - | - |
| 2026-03-23 | Winslow Garrett | +250,000 | - | - |
| 2026-03-23 | CAIN CHRISTOPHER W. | +37,313 | - | - |
| 2026-03-23 | Bruno Julianne | +37,313 | - | - |
| 2026-03-23 | Turtle Cameron | +37,313 | - | - |
| 2026-03-23 | Harwin Peter Evan | +37,313 | - | - |
| 2026-03-23 | Landsittel Michael | +37,313 | - | - |